Current role
Jessica Sachs
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jessica Sachs
The proxy statement of Cogent Biosciences, Inc. reports total compensation of $9,178,177 for Jessica Sachs in fiscal 2025, including a base salary of $549,389. Disclosed compensation is on record for 6 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Cogent Biosciences, Inc. (COGT)
Proxy statement
CurrentStart not stated–present
-
Start not stated–2020-04-29
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cogent Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrew Robbins CEO, Board Member
- Peter Harwin Chairman, Board Member
- John Green CFO
- John L. Green CFO
- Arlene M. Morris Board Member
- Chris Cain Board Member
- Chris Cain, Ph.D. Board Member
- Karen Ferrante Board Member
- Matthew E. Ros Board Member
- Todd E. Shegog Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $549,389 | $9,178,177 |
| 2024 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $527,436 | $1,832,714 |
| 2023 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $507,150 | $2,999,941 |
| 2022 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $482,558 | $1,907,927 |
| 2021 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $415,769 | $3,809,193 |
| 2020 | Cogent Biosciences, Inc. (COGT) | Chief Medical Officer | $278,738 | $1,189,457 |
Recent activity
No call appearances or filed executive changes recorded yet.